<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Immunophenotypical alterations with impact on the epithelial-mesenchymal transition (EMT) process in salivary gland adenoid cystic carcinomas.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Immunophenotypical alterations with impact on the epithelial-mesenchymal transition (EMT) process in salivary gland adenoid cystic carcinomas." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728137/bin/RJME-61-1-175-fig1.jpg"/> </div> <div class="text-side"> <h1>Immunophenotypical alterations with impact on the epithelial-mesenchymal transition (EMT) process in salivary gland adenoid cystic carcinomas.</h1> <p>CK AE1/AE3 reactivity in salivary ACC: (A) Solid type with intense and diffuses reactivity, but focally in the centre of large tumoral islands the intensity was obviously lower; (B) The reactivity was more obvious at the luminal cells that outline the few remaining lumens from the tumor islands with prevalent intensity at the apical and lateral borders; (C) An intermediate reactivity was recorded in the case of salivary ACC with tubular pattern; (D) In the tubular type, the reaction was more obvious in the luminal cells, with a prevalent endomembranous cytoplasmic pattern, especially at the luminal border; (E) Also, we noticed a reduce CK AE1/AE3 reactivity in the abluminal cells, and even absent in these cells from the invasive tubular neoplastic proliferations; (F) The lowest reactivity was recorded in the cribriform ACC subtype, which was obvious only at the level of the tubular proliferations. Anti-CK AE1/AE3 antibody immunomarking: (A) ×200; (B) ×400; (C) ×25; (D and E) ×600; (F) ×100. CK: Cytokeratin; ACC: Adenoid cystic carcinoma.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32747909/" target="_blank">32747909</a></p><p>Type: Premalignant/Malignant, Category: Adnexal</p>
</div> </div></div></body></html>